- Home
- OLMA vs GM Comparison
OLMA vs GM Comparison
Compare OLMA & GM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- GM
- Stock Information
- Founded
- OLMA 2006
- GM 1908
- Country
- OLMA United States
- GM United States
- Employees
- OLMA N/A
- GM N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- GM Auto Manufacturing
- Sector
- OLMA Health Care
- GM Consumer Discretionary
- Exchange
- OLMA Nasdaq
- GM Nasdaq
- Market Cap
- OLMA 299.7M
- GM 45.8B
- IPO Year
- OLMA 2020
- GM N/A
- Fundamental
- Price
- OLMA $4.63
- GM $52.71
- Analyst Decision
- OLMA Strong Buy
- GM Buy
- Analyst Count
- OLMA 4
- GM 16
- Target Price
- OLMA $24.50
- GM $52.25
- AVG Volume (30 Days)
- OLMA 827.7K
- GM 9.3M
- Earning Date
- OLMA 08-05-2025
- GM 07-22-2025
- Dividend Yield
- OLMA N/A
- GM 0.90%
- EPS Growth
- OLMA N/A
- GM N/A
- EPS
- OLMA N/A
- GM 6.95
- Revenue
- OLMA N/A
- GM $188,448,000,000.00
- Revenue This Year
- OLMA N/A
- GM N/A
- Revenue Next Year
- OLMA N/A
- GM $0.43
- P/E Ratio
- OLMA N/A
- GM $7.67
- Revenue Growth
- OLMA N/A
- GM 7.76
- 52 Week Low
- OLMA $2.86
- GM $38.96
- 52 Week High
- OLMA $16.62
- GM $61.24
- Technical
- Relative Strength Index (RSI)
- OLMA 55.54
- GM 61.84
- Support Level
- OLMA $4.60
- GM $51.41
- Resistance Level
- OLMA $5.01
- GM $53.96
- Average True Range (ATR)
- OLMA 0.27
- GM 1.23
- MACD
- OLMA 0.05
- GM 0.21
- Stochastic Oscillator
- OLMA 77.50
- GM 79.97
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About GM General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under three segments: GM North America, GM International, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its US market share leadership in 2022, after losing it to Toyota due to the chip shortage in 2021. 2024's share was 17.0%. The Cruise autonomous vehicle arm, which GM now owns outright, previously operated driverless geofenced AV robotaxi services in San Francisco and other cities, but after a 2023 accident, GM decided that it will focus on personal AVs. GM Financial became the company's captive finance arm in 2010 via the purchase of AmeriCredit.